Livsmed Inc (KOSDAQ:491000)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Medical Device Import/Export and Research and Development	51.19B	27.12B	17.27B	9.68B
Total	51.19B	27.12B	17.27B	9.68B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
South Korea	45.68B	23.43B	14.19B	8.06B
USA	3.07B	2.11B	1.69B	705.80M
Germany	962.26M	740.63M	507.51M	368.47M
Other	1.48B	839.86M	876.63M	544.47M
Total	51.19B	27.12B	17.27B	9.68B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error